Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | -1.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.32% |
| Dec 31, 2025 | 31.60% |
| Sep 30, 2025 | 42.78% |
| Jun 30, 2025 | 40.12% |
| Mar 31, 2025 | 26.71% |
| Dec 31, 2024 | 65.23% |
| Sep 30, 2024 | 181.80% |
| Jun 30, 2024 | 44.84% |
| Mar 31, 2024 | 33.07% |
| Dec 31, 2023 | 29.41% |
| Sep 30, 2023 | 50.33% |
| Jun 30, 2023 | 26.02% |
| Mar 31, 2023 | 73.66% |
| Dec 31, 2022 | 24.56% |
| Sep 30, 2022 | 2.80% |
| Jun 30, 2022 | 3.78% |
| Mar 31, 2022 | 39.27% |
| Dec 31, 2021 | -26.93% |
| Sep 30, 2021 | 79.28% |
| Jun 30, 2021 | 49.21% |